Close

Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals Dec 9, 2011 01:15PM
Notable Analyst Rating Changes 06/18: (MCP) (PCX) (MRVL) Upgraded; (SWKS) (CDXS) (RIMM) Downgraded Jun 20, 2011 10:56AM
Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine May 16, 2011 02:05PM
Barclays on Global Pharmaceuticals: Global Therapeutic Conference Preview: Multiple Sclerosis May 12, 2011 02:19PM
Notable Analyst Rating Changes 04/25: (TZOO) (BIIB) (GE) Upgraded; (VECO) (SLM) (NUE) Downgraded Apr 25, 2011 10:41AM


Apr 21, 2011 02:21PM Notable 52-Week Highs and Lows of the Day 04/21: (SIRI) (UNH) (BIIB) High; (TEVA) (ZSTN) (AMR) Low
Apr 21, 2011 01:56PM Barclays Maintains an 'Overweight' on Amgen (AMGN); Core Stable, XGEVA Strong, Strategy Next
Apr 21, 2011 01:55PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); PML Rate Change in 2011?
Apr 12, 2011 02:26PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); Initial Take on Laquinimod ALLEGRO Data
Apr 12, 2011 10:47AM Notable Analyst Rating Changes 04/12: (LVLT) (EIX) (BIIB) Upgraded; (WMS) (AON) (CSX) Downgraded
Mar 18, 2011 02:33PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); PML Rate Normalizes
Feb 2, 2011 01:22PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); Strong 4Q10, Headwinds Persist in 2011
Dec 17, 2010 03:00PM Barclays Maintains an 'Equalweight' on Elan Corp (ELN); Strong Gilenya Start May Translate to Tysabri Weakness
Dec 17, 2010 02:56PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); IMPACT RX Data Suggest Strong Gilenya Launch
Nov 17, 2010 01:13PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); PML Rate - It Did Not Stabilize
Sep 29, 2010 01:53PM Barclays Maintains an 'Equalweight' on Biogen Idec (BIIB); Hemophilia Roundtable Update
Sep 27, 2010 01:15PM Barclays on U.S. Biotechnology Weekly: Still Early in Biotech Upside Trade
Aug 31, 2010 01:14PM Barclays Maintains an 'Equalweight' Rating on Biogen Idec (BIIB); Positive Data for Second Oral Competitor; Incremental Negative
Jul 21, 2010 01:08PM Barclays Maintains an 'Equalweight' Rating on Biogen Idec (BIIB); 2Q Beats, But Potential Headwinds Ahead
Jan 5, 2010 10:56AM Notable Analyst Rating Changes 1/5: RSH, QCOM, BIIB, AXL, More Upgraded; CBY, V, BEXP, COG, CXO, More Downgraded
Sep 4, 2009 09:30AM David Moenning's Daily State of the Markets: If a Tree Falls In the Woods…
Sep 3, 2009 04:00PM Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
Jun 29, 2009 09:39AM Notable Analyst Rating Changes 6/29: DFS, LYG, TRW, BCS, JCP Upgraded; AA, SNY, BIIB, WW Downgraded
May 20, 2009 01:12PM Barclays Gets Bullish On US Biotechnology Sector (BBH)
May 20, 2009 07:47AM Barclays Upgrades Biogen Idec (BIIB) to Equalweight
Feb 9, 2009 11:51AM Barclays Downgrades Biogen (BIIB) to Underweight
Feb 9, 2009 10:21AM David Moenning's Daily State of the Markets: 2/9
Jan 28, 2009 09:43AM Notable Analyst Rating Changes 1/28: BBY, DO, CLX, AFL Upgraded; XOM, CNW, CIEN, UPS Downgraded
Jan 27, 2009 10:41AM David Moenning's Daily State of the Markets: 1/27
Jan 23, 2009 10:03AM Morning Movers 1/23: Wyeth (WYE) Higher On Bid Report; Microsemi (MSCC) Slammed On Results/Guidance
Jan 5, 2009 10:04AM David Moenning's Daily State of the Markets: 01/05